France · 
What does Sanofi invest in?
Sanofi invests most often at Series B and Venture (59% of the rounds on record), in sectors such as Biotechnology and Health Care.
Sanofi highlights
- 01
27 cheques in the last 12 months
- 02
Mostly Series B and Venture: 59% of its rounds
- 03
Sole investor in 8 rounds, median $25M
- 04
1 exits from the portfolio
What they do
- Type
- Investment firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyHealth Care
- Based in
- France
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first96 appearances
- 2026
22 rounds
- Aug
- Aug
- Jul
- Jul
- Jul
- Jun
- Jun
- Jun
- Jun
- May
- May
- Mar
- Mar
- Mar
- Feb
- Feb
- Feb
- Feb
- Jan
- Jan
- Jan
- Jan
- 2025
29 rounds
- Dec
- Dec
- Nov
- Nov
- Nov
- Oct
- Oct
- Oct
- OctQuantHealthVenture · ILUndisclosedWith 1 other
- Sept
- Sept
- Sept
- Jul
- Jul
- Jul
- Jun
- May
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 47 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
5+funds on filenumbered funds in its name
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Lumena PharmaceuticalsBought by Shire$260MMay 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
Elder Pharamaceuticals$351MNov 2013
PluromedUndisclosedMar 2012
Genzyme$20BFeb 2011
TargeGen$635MJun 2010
Fovea PharmaceuticalsUndisclosedOct 2009
Shantha Biotechnics$770MJul 2009
Merial Limited$4.0BJul 2009
BiPar Sciences$500MApr 2009